On the stock market since 2002, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
No real growth (5% a year). Red columns mark years that ended in a loss.
Executives buying with their own money is usually read as confidence in the company’s future.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Revenue Growth: Sales are growing slowly.
The stock trades 23% below its peak. The market has trimmed its expectations for the company.
Sales run at $11.8M a year. A small number, but proof the product has real buyers.
Over the last 12 months, company executives reported 67 buys and 1 sell. Management buying with its own money is usually read as a good sign.
It pays out $0.50 per share each year — regular cash for whoever holds the stock.
A loss of $7.1M against $11.8M in annual sales. And on top of that, sales fell from the year before.
Since the drop from its peak, buyer appetite hasn’t come back. Council score: 0/10.
The sales tempo runs behind the sector. Council score: 2/10.
On our five-subject report card, ENX sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: ENX is a high-risk stock — not yet profitable, and its future rides on its product catching on.